• leader board size

News

Sensi Brands Secures Major Cultivation Site in Bid for Overseas Expansion

RICHMOND HILL – Sensi Brands Inc. completed its purchase of Maricann Inc., gaining control of a sprawling production facility tailored for export markets. The deal, the company's biggest to date, centers on a 100-acre campus in Langton, Ontario, complete with a 350,000-square-foot hybrid greenhouse built to EU-GMP standards. The property holds potential for expansion up ...

December 2nd, 2025|Business|

High Tide Launches Europe’s First Canna Cabana Store in Berlin

BERLIN – High Tide Inc., the Calgary-based Cannabis retailer known for its discount club model, has cut the ribbon on its inaugural European outpost, a Canna Cabana store in central Berlin that sells accessories and lifestyle products tied to Cannabis culture. The 1,500-square-foot location in the vibrant Mitte district, mere steps from Alexanderplatz, Berlin's bustling ...

December 1st, 2025|International, Retail|

Conservative Think Tank Advocates Federal Cannabis Labeling Standards to Address State Disparities

WASHINGTON – A prominent conservative policy group has called for federal guidance on Cannabis product warnings, pointing to stark differences in state regulations that leave consumers with inconsistent information on health risks. The American Enterprise Institute (AEI), in a report released last month, analyzed labeling requirements across states where recreational Cannabis is legal and found ...

December 1st, 2025|Compliance|

Psyence BioMed Ventures into Psilocybin’s Role in Aging Research

NEW YORK – Psyence BioMedical Ltd. disclosed its entry into longevity science with a new program probing psilocybin's influence on key aging indicators. The initiative, conducted alongside South African academics, marks the company's first foray beyond mental health applications and establishes it as the sole public firm pursuing this angle on the Schedule I substance. ...

December 1st, 2025|Psychedelics|

Kenyan MP Advocates for Regulated Cannabis Framework

NAIROBI – Peter Kalerwa Salasya, the outspoken member of Parliament for Kenya's Mumias East constituency, has ignited fresh debate on Сannabis policy by urging the government to pursue legalization under strict controls. Salasya highlighted the perils of Kenya's current unregulated market, where sellers peddle products without basic knowledge of their contents or effects. His remarks, ...

December 1st, 2025|International|

OPINION: The Looming Federal Clampdown on THC Drinks and Hemp-Derived Edibles: What It Means for the Industry

NEW YORK- The quiet addition of a single paragraph in November’s federal shutdown bill has sent shockwaves through one of the fastest-growing segments of U.S. Cannabis: hemp-derived THC beverages and edibles. Unless Congress intervenes, a nationwide ban on intoxicating hemp products will go into effect in November 2026, threatening thousands of businesses and reshaping a ...

November 29th, 2025|Business, Insights|

New York State OCM Updates Medical Cannabis Program, Expands Access for Out-of-State Patients

ALBANY – Governor Kathy Hochul signed a bill into law that extends New York's medical Cannabis program to patients certified in other states, marking the most substantial revision to the initiative since its 2016 launch. The measure, Senate Bill 2025-S3294A, also streamlines certification for residents and introduces home cultivation options, aiming to cut administrative barriers ...

November 28th, 2025|Local Politics|

New Brunswick Government Bets on Organigram with $2M Grant

MONCTON – Organigram Global Inc. has secured $2 million in provincial funding to support a $9.3 million project aimed at revamping its flagship cultivation site here. The upgrade, which targets lighting systems across 75 grow rooms, seeks to lift output by 10% while sharpening operational edges in a competitive market. Opportunities New Brunswick, the province's ...

November 27th, 2025|International|

Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone

DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical Cannabis sector. The figures highlight Epidiolex®'s role as a consistent performer in Jazz's lineup. Net product sales hit $302.6 million ...

November 27th, 2025|International, Investors|

Medicare Explores CBD Coverage for Seniors

WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by the federal government into cannabinoid therapies. The initiative, detailed in a forthcoming Federal Register proposal, targets patients in oncology and ...

November 27th, 2025|People|

How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn

LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and innovators all show up in the same place. Yet year after year, the same mistake repeats: brands spend tens of ...

November 25th, 2025|Business, Insights|

New Jersey Assembly Panel Clears Path for Psilocybin Therapy Program

TRENTON – New Jersey lawmakers advanced a bill that would allow supervised access to psilocybin for adults facing certain health challenges, establishing a regulated psilocybin therapy framework approved by the Assembly Health Committee. Assemblymember Anthony Verrelli, a Democrat and co-sponsor of the measure, framed the legislation during testimony as a targeted response to unmet mental ...

November 25th, 2025|Psychedelics|

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – Operators and investors in Cannabis and Psychedelics faced a week of sharp contrasts. Federal action ended the longest government shutdown on record, yet it delivered a body blow to hemp-derived products that could reshape supply chains and consumer access. Big Pharma doubled down on psychedelic innovation with a blockbuster deal, while MSOs ...

November 24th, 2025|Business, The Week in Review|

Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations

BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark a cautious expansion of therapies using psilocybin, with Switzerland also permitting limited use of LSD and MDMA, signaling a shift ...

November 21st, 2025|Psychedelics|

Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase

SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings Ltd. and extend its operational cash flow for more than a year. The deal, announced this week, involves U.S.-based lenders ...

November 20th, 2025|Business, International|

West Virginia Medical Cannabis Costs Drive Patients Across State Lines for Lower-Priced Options

CHARLESTON – Elevated prices in West Virginia's medical Cannabis system continue to steer registered patients toward recreational outlets in Ohio, Maryland, and Michigan, where products sell at fractions of the cost despite legal barriers to transport. The state's program, active since 2017 with dispensaries opening in 2021, now counts 35,000 cardholders, but registrations have stalled ...

November 20th, 2025|Markets|

Florida Takes Action to Advance Adult-Use Cannabis Ballot Measure, Lawsuit Ends Delay

TALLAHASSEE – Florida election officials cleared a procedural roadblock for a proposed constitutional amendment to legalize recreational Cannabis, submitting the measure to the state attorney general's office just weeks after advocates sued over perceived delays in the review process. The move sets the stage for scrutiny by the Florida Supreme Court on the ballot language's ...

November 19th, 2025|Local Politics|

Viridian Capital Advisors Reports Valuation Metrics for U.S. MSOs with Market Caps >$100M

LOS ANGELES – Multi-state cannabis operators in the United States are carrying valuation multiples that signal caution among investors, even as growth prospects brighten for the coming year. According to a fresh Weekly Valuation Report from Viridian Capital Advisors, the 11 publicly traded MSOs with market capitalizations exceeding $100 million posted a median enterprise value ...

November 18th, 2025|Insights|

OPINION: Industrial hemp just got ‘future proofed.’

NEW YORK- Industrial hemp just received the clearest signal yet that it's not a fad, not a loophole, and not going away. It was effectively declared “future proof.” When Congress passed the funding bill to reopen the federal government last week, it did more than end a shutdown. It rewrote the rules for the entire ...

November 17th, 2025|Business, Insights|

New York Updates Cannabis Packaging, Labeling, and Advertising Regulations

NEW YORK – The New York State Cannabis Control Board finalized amendments to its packaging, labeling, marketing, and advertising regulations, marking a significant step in refining the state's adult-use Cannabis market. The changes aim to enhance consumer safety, curb youth appeal, and promote environmental responsibility, while offering operators clearer guidelines for compliance. The adoption follows ...

November 14th, 2025|Compliance|

Planet 13 Reports Q3 2025 Financial Results

LAS VEGAS – Planet 13 Holdings Inc., a multistate Cannabis operator with flagship operations in Nevada and Florida, disclosed a $44 million net loss for the third quarter, reflecting the toll of compressed prices, softening demand, and one-time charges across its portfolio. Revenue fell to $23.3 million, a 27.6% drop from $32.2 million a year ...

November 14th, 2025|Report|
Go to Top